Reckitt Benckiser (Bangladesh) PLC announcements
298 Dhaka Stock Exchange announcements for Reckitt Benckiser (Bangladesh) PLC (RECKITTBEN) since 2007: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2026 (15).
- Q3 Financials
(Q3 Un-audited): EPS was Tk. 56.86 for July-September 2026 as against Tk. 52.22 for July-September 2025; EPS was Tk. 121.20 for January-September 2026 as against Tk. 114.38 for January-September 2025. NOCFPS was Tk. 266.68 for January-September 2026 as against Tk. 161.18 for January-September 2025. NAV per share was Tk. 135.96 as on September 30, 2026 and Tk. 187.58 as on December 31, 2025. (cont.) (Cont. News of RECKITTBEN): Reasons for deviation: Net cash inflow from operating activities increased to BDT 1260.08 million for the nine months ended 30 September 2026 compared to 2025, primarily driven by lower payment and increased collection during the period. (end)
- Cancellation of old & execution of new license agreements
The company has informed the following being acknowledged by the Board of Directors meeting held on 29 October 2026: Cancellation of old agreements: i. Acknowledged the cancelation of license agreement dated 10 April 2019 and first addendum dated 08 August 2023 between Reckitt Benckiser (Bangladesh) PLC and Reckitt Benckiser (ENA) B.V, The Netherlands with effect from 31 December 2025. Royalty rate was between 3.5% to 5% of the net revenue for the selected brands. (cont.1) (Cont. news of RECKITTBEN): Royalty rate would be 6% of the net revenue for the selected brands. The agreement will be submitted to BIDA for approval, and they will notify once such approval is obtained. (end) (Cont. news of RECKITTBEN): Reckitt Benckiser Health Limited, Uk with effect from 1st January 2026, Royalty rate would be 6% of the net revenue for the selected brands. The agreement will be submitted to BIDA for approval, and they will notify once such approval is obtained. iii. Acknowledged the execution of new license agreement between Reckitt Benckiser (Bangladesh) PLC and Reckitt Benckiser LLC, USA with effect from 1st January 2026. (cont.4) (Cont. news of RECKITTBEN): The Netherlands with effect from 1st January 2026. Royalty rate would be 6% of the net revenue for the selected brands. The agreement will be submitted to BIDA for approval, and they will notify once such approval is obtained. ii. Acknowledged the execution of new license agreement between Reckitt Benckiser (Bangladesh) PLC and (cont.3) (Cont. news of RECKITTBEN): ii. Acknowledged the cancelation of license agreement dated 10 April 2019 and first addendum dated 08 August 2023 between Reckitt Benckiser (Bangladesh) PLC and Reckitt Benckiser Health limited, UK with effect from 31 December 2025. Royalty rate was 6% of the net revenue for the selected brands. Execution of New License Agreements: i. Acknowledged the execution of new license agreement between Reckitt Benckiser (Bangladesh) PLC and Reckitt Benckiser (ENA) B.V, (cont.2)
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 29, 2026 at 4:00 PM to consider, among others, Un-Audited Financial Statements for the Third Quarter (Q3) period ended September 30, 2026.
- Credit Rating Result
Credit Rating Information and Services PLC (CRISL) has assigned the company as "AAA" in the long term and "ST-1" in the short term along with Stable outlook in consideration of its audited financials up to December 31, 2025, also unaudited financials up to June 30, 2026 and other relevant quantitative as well as qualitative information up to the date of rating declaration.
- Dividend Disbursement
The Company has informed that it has disbursed the Cash Dividend for the year ended December 31, 2025 to the respective shareholders.
- Q2 Financials
(Q2 Un-audited): EPS was Tk. 41.07 for April-June 2026 as against Tk. 29.71 for April-June 2025; EPS was Tk. 64.34 for January-June 2026 as against Tk. 62.16 for January-June 2025. NOCFPS was Tk. 153.51 for January-June 2026 as against Tk. 98.13 for January-June 2025. NAV per share was Tk. 79.09 as on June 30, 2026 and Tk. 187.58 as on December 31, 2025. (cont.1) (Cont. News of RECKITTBEN): Decline in NAVPS as of 30 June 2026 compared with 31 December 2025: NAVPS decreased primarily because the dividend approved for the year ended 31 December 2025 was transferred from retained earnings to dividend payable after the AGM on 30 June 2026. So, the closing retained earnings include current year (2026) profits. (end) (Cont. News of RECKITTBEN): Improved Net Operating Cash Flow per share in Q2'2026: Net cash inflow from operating activities increased to BDT 725.4 million for the six months ended 30 June 2026, up 56.4% from the comparative period of 2025, primarily driven by stronger business performance in Q2 2026, following a slower first quarter impacted by fewer business days due to the Eid holiday period. (cont.3) (Cont. News of RECKITTBEN): Reasons for deviation: Improved EPS in Q2'2026 vs Q2'2025: The company reported 6.69% revenue growth in Q2 2026 compared to Q2 2025, driven by stronger business performance, as Q2 2025 was impacted by reduced business days due to two Eid holidays. Improved EPS in Q2'2026 vs Q2'2025: The company reported 7.42% revenue growth in Q2 2026 compared to Q1, following a slower first quarter impacted by fewer business days due to the Eid holiday and National election. (cont.2)
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on July 29, 2026 at 4:00 pm to consider, among others, Un-Audited Financial Statements for the Second Quarter (Q2) period ended June 30, 2026.
- Resumption after Record Date
Trading of the shares of the company will resume on 23.05.2026.
- Suspension for Record Date
Trading of the shares of the company will remain suspended on record date i.e., 21.05.2026.
- Spot News
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 19.05.2026 to 20.05.2026 and trading of the shares will remain suspended on record date i.e., 21.05.2026.
- Dividend Declaration
The Board of Directors has recommended 1,730% Final Cash Dividend i.e., @ Tk. 173 per Share of Face Value of Tk. 10/- each for the year ended December 31, 2025. Date of AGM: 29th June 2026 at 11.00 A.M., Venue: Virtual Meeting through digital platform. Record Date: May 21, 2026. (cont.) (Cont. News of RECKITTBEN): The Company has also reported EPS of Tk. 172.93, NAV per share of Tk. 187.58 and NOCFPS of Tk. 170.67 for the year ended December 31, 2025 as against Tk. 159.17, Tk. 350.64 and Tk. 22.55 respectively for the year ended December 31, 2024. (end)
- Price Limit Open
There will be no price limit on the trading of the shares of the Company today (03.05.2026) following its corporate declaration.
- Q1 Financials
(Q1 Un-audited): EPS was Tk. 23.26 for January-March 2026 as against Tk. 32.45 for January-March 2025. NOCFPS was Tk. 75.60 for January-March 2026 as against Tk. 79.64 for January-March 2025. NAV per share was Tk. 210.85 as on March 31, 2026 and Tk. 187.58 as on December 31, 2025.
- Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 30, 2026 at 3:20 PM to consider, among others, audited financial statements of the Company for the year ended December 31, 2025.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 30, 2026 at 3:20 pm to consider, among others, Un-Audited Financial Statements for the First Quarter (Q1) period ended March 31, 2026.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.